{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:51Z","timestamp":1753891911059,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:00:00Z","timestamp":1523923200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00391","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T04:14:25Z","timestamp":1523938465000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["In Vivo Pharmacokinetic\/Pharmacodynamic Profiles of Danofloxacin in Rabbits Infected With Salmonella typhimurium After Oral Administration"],"prefix":"10.3389","volume":"9","author":[{"given":"Xia","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Jie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Xuan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Yu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yon-Jia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1090-0233(02)00258-7","article-title":"Pharmacokinetics and PK-PD modelling of danofloxacin in camel serum and tissue cage fluids.","volume":"165","author":"Aliabadi","year":"","journal-title":"Vet. J."},{"key":"B2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/AAC.47.2.626-635.2003","article-title":"Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids.","volume":"47","author":"Aliabadi","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0924-8579(02)00022-5","article-title":"Animal model pharmacokinetics and pharmacodynamics: a critical review.","volume":"19","author":"Andes","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.coph.2017.09.004","article-title":"In vivo infection models in the pre-clinical pharmacokinetic\/pharmacodynamic evaluation of antimicrobial agents.","volume":"36","author":"Andes","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"8331","DOI":"10.1073\/pnas.1400352111","article-title":"Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections.","volume":"111","author":"Ankomah","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1128\/AAC.45.2.433-438.2001","article-title":"Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae.","volume":"45","author":"Blondeau","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B7","first-page":"61","author":"Burton","year":"2005","journal-title":"Applied Pharmacokinetics &amp; Pharmacodynamics: Principles of Therapeutic Drug Monitoring."},{"key":"B8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.rvsc.2012.10.015","article-title":"Phenotypic and genetic traits of Salmonella enterica subsp. serovar Typhimurium strains causing salmonellosis foci in rabbit farms from Southern Italy in 1999-2003.","volume":"94","author":"Camarda","year":"2013","journal-title":"Res. Vet. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4161\/viru.26514","article-title":"The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host.","volume":"5","author":"Christaki","year":"2014","journal-title":"Virulence"},{"journal-title":"Performance Standards for Antimicrobial Susceptibility Testing; 23rd Informational Supplement. Document M100-S23.","year":"2013","key":"B10"},{"key":"B11","doi-asserted-by":"publisher","first-page":"z11","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.","volume":"26","author":"Craig","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.meatsci.2011.02.017","article-title":"The role of rabbit meat as functional food.","volume":"88","author":"Dalle Zotte","year":"2011","journal-title":"Meat Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-2885.2007.00807.x","article-title":"Pharmacokinetic-pharmacodynamic integration of danofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits.","volume":"30","author":"Fernandez-Varon","year":"2007","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/(SICI)1099-0801(200004)14:2<89::AID-BMC931>3.0.CO;2-N","article-title":"Development of a method for the determination of danofloxacin in plasma by HPLC with fluorescence detection.","volume":"14","author":"Garcia","year":"2000","journal-title":"Biomed. Chromatogr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.vetmic.2011.07.033","article-title":"Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs.","volume":"154","author":"Gebru","year":"2012","journal-title":"Vet. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/00071660903147416","article-title":"Disposition kinetics and tissue residues of danofloxacin in Muscovy ducks.","volume":"50","author":"Goudah","year":"2009","journal-title":"Br. Poult. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1128\/AAC.02065-15","article-title":"In Vivo pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Streptococcus suis serotype 2 at varied initial inoculum sizes.","volume":"60","author":"Guo","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.fct.2011.03.044","article-title":"Pharmacokinetic-pharmacodynamic indices of enrofloxacin in Escherichia coli O78\/H12 infected chickens.","volume":"49","author":"Haritova","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s11259-006-3400-7","article-title":"Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys.","volume":"30","author":"Haritova","year":"2006","journal-title":"Vet. Res. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.vetmic.2008.04.020","article-title":"Shedding of food-borne pathogens and microbiological carcass contamination in rabbits at slaughter.","volume":"132","author":"Kohler","year":"2008","journal-title":"Vet. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00542","article-title":"Pharmacokinetic and pharmacodynamic evaluation of marbofloxacin and PK\/PD modeling against Escherichia coli in pigs.","volume":"8","author":"Lei","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12294-7","article-title":"The effects of different enrofloxacin dosages on clinical efficacy and resistance development in chickens experimentally infected with Salmonella Typhimurium.","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/jvp.12409","article-title":"Pharmacokinetics, milk penetration and PK\/PD analysis by Monte Carlo simulation of marbofloxacin, after intravenous and intramuscular administration to lactating goats.","volume":"30","author":"Lorenzutti","year":"2017","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1128\/CMR.00002-11","article-title":"Food animals and antimicrobials: impacts on human health.","volume":"24","author":"Marshall","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/jac\/dkg211","article-title":"Fluoroquinolone benchmarking in relation to pharmacokinetic and pharmacodynamic parameters.","author":"Paladino","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2174\/1389200218666170710185032","article-title":"Quinolones and fluoroquinolones metabolism and resistance in Salmonella typhimurium: a mini review.","volume":"18","author":"Preethi","year":"2017","journal-title":"Curr. Drug Metab."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-015-0608-1","article-title":"Pharmacokinetics\/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model.","volume":"11","author":"Qu","year":"2015","journal-title":"BMC Vet. Res."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/vr.103964","article-title":"Susceptibility and PK\/PD relationships of Staphylococcus aureus strains from ovine and caprine with clinical mastitis against five veterinary fluoroquinolones.","volume":"180","author":"Serrano-Rodriguez","year":"2017","journal-title":"Vet. Rec."},{"key":"B29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0034-5288(03)00005-5","article-title":"Pharmacokinetic-pharmacodynamic integration of danofloxacin in the calf.","volume":"74","author":"Shojaee Aliabadi","year":"2003","journal-title":"Res. Vet. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1128\/AAC.00260-15","article-title":"Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis.","volume":"59","author":"Swanson","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0034-5288(02)00039-5","article-title":"The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics.","volume":"73","author":"Toutain","year":"2002","journal-title":"Res. Vet. Sci."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00174","article-title":"Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research.","volume":"5","author":"Tuntland","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1128\/AAC.00200-15","article-title":"In vivo pharmacokinetic\/pharmacodynamic profiles of valnemulin in an experimental intratracheal Mycoplasma gallisepticum infection model.","volume":"59","author":"Xiao","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/jvp.12065","article-title":"Mycoplasma gallisepticum and Escherichia coli mixed infection model in broiler chickens for studying valnemulin pharmacokinetics.","volume":"37","author":"Xiao","year":"2014","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/jvp.12162","article-title":"Estimating danofloxacin withdrawal time in broiler chickens based on physiologically based pharmacokinetics modeling.","volume":"38","author":"Yang","year":"2015","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00926","article-title":"The PK-PD relationship and resistance development of Danofloxacin against Mycoplasma gallisepticum in An In Vivo infection model.","volume":"8","author":"Zhang","year":"2017","journal-title":"Front. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.tvjl.2014.05.010","article-title":"Integration of pharmacokinetic and pharmacodynamic indices of valnemulin in broiler chickens after a single intravenous and intramuscular administration.","volume":"201","author":"Zhao","year":"2014","journal-title":"Vet. J."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00391\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T04:14:31Z","timestamp":1523938471000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00391\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,17]]},"references-count":37,"alternative-id":["10.3389\/fphar.2018.00391"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00391","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2018,4,17]]},"article-number":"391"}}